Invention Grant
- Patent Title: Lyssavirus antigen constructs
-
Application No.: US16630951Application Date: 2018-07-16
-
Publication No.: US11278613B2Publication Date: 2022-03-22
- Inventor: Kathryn Hashey , Padma Malyala , Marcelo Samsa , Olga Slack , Dong Yu , Alan Stokes , Rashmi Jalah
- Applicant: GLAXOSMITHKLINE BIOLOGICALS SA
- Applicant Address: BE Rixensart
- Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
- Current Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
- Current Assignee Address: BE Rixensart
- Agency: Birch, Stewart, Kolasch & Birch, LLP
- International Application: PCT/IB2018/055258 WO 20180716
- International Announcement: WO2019/016680 WO 20190124
- Main IPC: A61K39/205
- IPC: A61K39/205 ; A61K9/127 ; A61K39/00
Abstract:
Nucleic acid based vaccine constructs encoding Lyssaviral antigens are useful in preventing and treating diseases. Self-amplifying RNA molecules encoding Lyssaviral antigens provide potent and long-lasting immunity.
Public/Granted literature
- US20200222526A1 LYSSAVIRUS ANTIGEN CONSTRUCTS Public/Granted day:2020-07-16
Information query
